C. Laffon-de-mazieres, M. Lapeyre-mestre, and B. Vellas, Organizational Factors Associated With Inappropriate Neuroleptic Drug Prescribing in Nursing Homes: A Multilevel Approach, Journal of the American Medical Directors Association, vol.16, issue.7, pp.590-597, 2015.
DOI : 10.1016/j.jamda.2015.01.092

C. Cool, P. Cestac, and C. Laborde, Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes, Journal of the American Medical Directors Association, vol.15, issue.11, 2014.
DOI : 10.1016/j.jamda.2014.08.003

P. Barreto, M. Lapeyre-mestre, and C. Mathieu, Indicators of Benzodiazepine Use in Nursing Home Residents in France: A Cross-Sectional Study, Journal of the American Medical Directors Association, vol.14, issue.1, pp.29-33, 2013.
DOI : 10.1016/j.jamda.2012.09.002

URL : https://hal.archives-ouvertes.fr/halshs-00847487

F. Montastruc, V. Gardette, and C. Cantet, Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!, European Journal of Clinical Pharmacology, vol.29, issue.8, pp.1589-97, 2013.
DOI : 10.1007/s00228-013-1506-8

S. Ruths, P. Sorensen, and O. Kirkevold, Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts, International Journal of Geriatric Psychiatry, vol.23, issue.8, pp.868-76, 2013.
DOI : 10.1002/gps.3902

L. Carton, O. Cottencin, and M. Lapeyre-mestre, Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends, Current Pharmaceutical Design, vol.21, issue.23, pp.3280-97, 2015.
DOI : 10.2174/1381612821666150619092903

Y. Wei, L. Simoni-wastila, and I. Zuckerman, Quality of Psychopharmacological Medication Prescribing and Mortality in Medicare Beneficiaries in Nursing Homes, Journal of the American Geriatrics Society, vol.22, issue.Suppl 2, pp.1490-504, 2014.
DOI : 10.1111/jgs.12939

J. Bourgeois, M. Elseviers, and M. Azermai, Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages, European Journal of Clinical Pharmacology, vol.26, issue.1, pp.833-877, 2012.
DOI : 10.1007/s00228-011-1188-z

A. Iaboni, S. Bronskill, and K. Reynolds, Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study, Drugs & Aging, vol.18, issue.3, pp.523-556, 2016.
DOI : 10.1007/s40266-016-0380-3

C. Johnson, C. Frei, and N. Downes, Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study, British Journal of General Practice, vol.66, issue.647, pp.410-415, 2016.
DOI : 10.3399/bjgp16X685213

K. Lapane, A. Hume, C. Ulbricht, and G. Gambassi, Safety of Psychotropic Drugs in the Elderly, Pharmacovigilance in psychiatry. Switzerland, pp.285-97, 2016.
DOI : 10.1007/978-3-319-24741-0_14

C. Manson, R. Gordon, and D. Baldwin, Safety and Tolerability of Antidepressants, Pharmacovigilance in psychiatry. Switzerland, pp.149-66, 2016.
DOI : 10.1007/978-3-319-24741-0_8

M. Jann and W. Kennedy, Safety and Tolerability of Antipsychotics, Pharmacovigilance in psychiatry. Switzerland, pp.167-89, 2016.
DOI : 10.1007/978-3-319-24741-0_9

V. Arcoraci and E. Spina, Safety and tolerability of anxiolytics/sedative-hypnotics Pharmacovigilance home residents with dementia: a retrospective cohort study, J Clin Psychiatry, vol.70, issue.10, pp.1340-1347, 2009.

L. Simoni-wastila, P. Ryder, and J. Qian, Association of Antipsychotic Use With Hospital Events and Mortality Among Medicare Beneficiaries Residing in Long-Term Care Facilities, The American Journal of Geriatric Psychiatry, vol.17, issue.5, pp.417-444, 2009.
DOI : 10.1097/JGP.0b013e31819b8936

J. Jalbert, C. Eaton, S. Miller, and K. Lapane, Antipsychotic Use and the Risk of Hip Fracture Among Older Adults Afflicted With Dementia, Journal of the American Medical Directors Association, vol.11, issue.2, pp.120-127, 2010.
DOI : 10.1016/j.jamda.2009.10.001

K. Huybrechts, K. Rothman, and R. Silliman, Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes, Canadian Medical Association Journal, vol.183, issue.7, pp.411-420, 2011.
DOI : 10.1503/cmaj.101406

K. Huybrechts, T. Gerhard, and S. Crystal, Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study, BMJ, vol.344, issue.feb23 2, 2012.
DOI : 10.1136/bmj.e977

C. Sterke, E. Van-beeck, and N. Van-der-velde, New Insights: Dose-Response Relationship Between Psychotropic Drugs and Falls: A Study in Nursing Home Residents With Dementia, The Journal of Clinical Pharmacology, vol.9, issue.suppl 4, pp.947-55, 2012.
DOI : 10.1177/0091270011405665

K. Huybrechts, S. Schneeweiss, and T. Gerhard, Comparative Safety of Antipsychotic Medications in Nursing Home Residents, Journal of the American Geriatrics Society, vol.47, issue.3
DOI : 10.1111/j.1532-5415.2011.03853.x

J. Van-de-ven-vakhteeva, H. Bor, and R. Wetzels, The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes, International Journal of Geriatric Psychiatry, vol.20, issue.1, pp.530-538, 2013.
DOI : 10.1002/gps.3858

S. Dutcher, G. Rattinger, and P. Langenberg, Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia, Journal of the American Geriatrics Society, vol.44, issue.6, pp.1046-55, 2014.
DOI : 10.1111/jgs.12838

R. Aparasu, S. Chatterjee, and H. Chen, Risk of Hospitalization and Use of First- Versus Second-Generation Antipsychotics Among Nursing Home Residents, Psychiatric Services, vol.65, issue.6, pp.781-789, 2014.
DOI : 10.1176/appi.ps.201300093

T. Huang, Y. Wei, and P. Moyo, Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias, Journal of the American Geriatrics Society, vol.56, issue.Suppl 1, pp.1757-65, 2015.
DOI : 10.1111/jgs.13606

M. Sahlberg, E. Holm, and G. Gislason, Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons, Journal of the American Heart Association, vol.4, issue.9, 2015.
DOI : 10.1161/JAHA.114.001666

S. Bozat-emre, M. Doupe, and A. Kozyrskyj, Atypical antipsychotic drug use and falls among nursing home residents in Winnipeg, Canada, International Journal of Geriatric Psychiatry, vol.4, issue.8, pp.842-50, 2015.
DOI : 10.1002/gps.4223

L. Simoni-wastila, Y. Wei, and J. Lucas, Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications, Journal of the American Geriatrics Society, vol.22, issue.Suppl 2, pp.973-80, 2016.
DOI : 10.1111/jgs.14111

S. Berry, S. Placide, and E. Mostofsky, Antipsychotic and Benzodiazepine Drug Changes Affect Acute Falls Risk Differently in the Nursing Home, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.71, issue.2, pp.273-281, 2016.
DOI : 10.1093/gerona/glv091

Y. Wei, L. Simoni-wastila, J. Lucas, and N. Brandt, Fall and Fracture Risk in Nursing Home Residents With Moderate-to-Severe Behavioral Symptoms of Alzheimer???s Disease and Related Dementias Initiating Antidepressants or Antipsychotics, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, pp.10-1093, 2016.
DOI : 10.1093/gerona/glw095

Y. Park, J. Franklin, and S. Schneeweiss, Antipsychotics and Mortality: Adjusting for Mortality Risk Scores to Address Confounding by Terminal Illness, Journal of the American Geriatrics Society, vol.23, issue.3, pp.516-539, 2015.
DOI : 10.1111/jgs.13326

M. Snowden, K. Sato, and P. Roy-byrne, Assessment and Treatment of Nursing Home Residents with Depression or Behavioral Symptoms Associated with Dementia: A Review of the Literature, Journal of the American Geriatrics Society, vol.39, issue.(S, pp.1305-1322, 2003.
DOI : 10.1046/j.1532-5415.2003.51417.x

C. Ballard, J. Waite, and J. Birks, Atypical antipsychotics for aggression and psychosis in Alzheimer's disease, Cochrane Database Syst Rev, vol.31, issue.1, 2006.
DOI : 10.1002/14651858.CD003476.pub2

E. Lonergan, J. Luxenberg, and A. Sastre, Benzodiazepines for delirium, Cochrane Database Syst Rev, 2009.
DOI : 10.1002/14651858.cd006379

D. Seitz, N. Adunuri, and S. Gill, Antidepressants for agitation and psychosis in dementia, Cochrane Database Syst Rev, 2011.

G. Martinon-torres, M. Fioravanti, and E. Grimley, Trazodone for agitation in dementia, Cochrane Database Syst Rev, vol.155, issue.3, 2004.
DOI : 10.1002/14651858.CD004990

J. Mccleery, D. Cohen, and A. Sharpley, Pharmacotherapies for sleep disturbances in Alzheimer's disease, Cochrane Database Syst Rev, 2014.

J. Bourgeois, M. Elseviers, and L. Van-bortel, Sleep quality of benzodiazepine users in nursing homes: A comparative study with nonusers, Sleep Medicine, vol.14, issue.7, pp.614-635, 2013.
DOI : 10.1016/j.sleep.2013.03.012

J. Bourgeois, M. Elseviers, and L. Van-bortel, One-Year Evolution of Sleep Quality in Older Users of Benzodiazepines: A Longitudinal Cohort Study in Belgian Nursing Home Residents, Drugs & Aging, vol.43, issue.1, pp.677-82, 2014.
DOI : 10.1007/s40266-014-0203-3

J. Bourgeois, M. Elseviers, and L. Van-bortel, The impact of chronic benzodiazepine use on cognitive evolution in nursing home residents, Human Psychopharmacology: Clinical and Experimental, vol.17, issue.3, pp.85-93, 2015.
DOI : 10.1002/hup.2456

T. Declercq, M. Petrovic, and M. Azermai, Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia, Cochrane Database Syst Rev, vol.20, issue.2, 2013.
DOI : 10.1002/14651858.CD007726.pub2

C. Yury and J. Fisher, Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia, Psychother Psychosom, vol.76, issue.4, pp.213-221, 2007.

Y. Chiu, L. Bero, and N. Hessol, A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents, Health Policy, vol.119, issue.6, pp.802-815, 2015.
DOI : 10.1016/j.healthpol.2015.02.014

D. Maust, H. Kim, and L. Seyfried, Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia, JAMA Psychiatry, vol.72, issue.5, pp.438-483, 2015.
DOI : 10.1001/jamapsychiatry.2014.3018

V. Gardette, M. Lapeyre-mestre, and N. Coley, Antipsychotic Use and Mortality Risk in Community-Dwelling Alzheimer???s Disease Patients: Evidence for a Role of Dementia Severity, Current Alzheimer Research, vol.9, issue.9, pp.1106-1122, 2012.
DOI : 10.2174/156720512803569037

B. Danielsson, C. J. Bergman, and G. , Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study, British Journal of Clinical Pharmacology, vol.59, issue.4, pp.773-83, 2016.
DOI : 10.1136/bmj.f288

A. Foebel, G. Onder, and H. Finne-soveri, Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia, Journal of the American Medical Directors Association, vol.17, issue.2, 2016.
DOI : 10.1016/j.jamda.2015.11.014

M. De-groot, J. Van-campen, and M. Moek, The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review, Drugs & Aging, vol.23, issue.1, pp.901-921, 2013.
DOI : 10.1007/s40266-013-0113-9

A. Ballokova, N. Peel, and D. Fialova, Use of Benzodiazepines and Association with Falls in Older People Admitted to Hospital: A Prospective Cohort Study, Drugs & Aging, vol.32, issue.3, pp.299-310, 2014.
DOI : 10.1007/s40266-014-0159-3

C. Sterke, G. Ziere, and E. Van-beeck, Dose-response relationship between selective serotonin re-uptake inhibitors and injurious falls: a study in nursing home residents with dementia, British Journal of Clinical Pharmacology, vol.29, issue.4
DOI : 10.1111/j.1365-2125.2011.04124.x

F. Moulis, G. Moulis, and L. Balardy, Exposure to Atropinic Drugs and Frailty Status, Journal of the American Medical Directors Association, vol.16, issue.3, pp.253-260, 2015.
DOI : 10.1016/j.jamda.2014.11.017

R. Rizzoli, C. Cooper, and J. Reginster, Antidepressant medications and osteoporosis, Bone, vol.51, issue.3, pp.606-619, 2012.
DOI : 10.1016/j.bone.2012.05.018

URL : http://orbi.ulg.ac.be/request-copy/2268/129245/142975/Antidepressant%20medications%20and%20osteoporosis.pdf

E. Souchet, M. Lapeyre-mestre, and J. Montastruc, Drug related falls: a study in the French Pharmacovigilance database, Pharmacoepidemiology and Drug Safety, vol.57, issue.1, pp.11-17, 2005.
DOI : 10.1002/pds.1038

G. Trifiró, J. Sultana, and E. Spina, Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies, Drug Safety, vol.158, issue.6, pp.501-521, 2014.
DOI : 10.1007/s40264-014-0170-y

G. Gambassi, J. Sultana, and G. Trifirò, Antipsychotic use in elderly patients and the risk of pneumonia, Expert Opinion on Drug Safety, vol.14, issue.1, 2015.
DOI : 10.1002/gps.3999

M. Nosè, E. Recla, G. Trifirò, and C. Barbui, Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies, Pharmacoepidemiology and Drug Safety, vol.34, issue.8, pp.812-832, 2015.
DOI : 10.1002/pds.3804

N. Vozoris, H. Fischer, and X. Wang, Benzodiazepine Use among Older Adults with Chronic Obstructive Pulmonary Disease, Drugs & Aging, vol.22, issue.3, pp.183-92, 2013.
DOI : 10.1007/s40266-013-0056-1

N. Vozoris, H. Fischer, and X. Wang, Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD, European Respiratory Journal, vol.44, issue.2, pp.332-372, 2014.
DOI : 10.1183/09031936.00008014

J. Jalbert, L. Daiello, C. Eaton, S. Miller, and K. Lapane, Antipsychotic Use and the Risk of Diabetes in Nursing Home Residents with Dementia, The American Journal of Geriatric Pharmacotherapy, vol.9, issue.3, pp.153-63, 2011.
DOI : 10.1016/j.amjopharm.2011.04.006

M. Laroche, M. Perault-pochat, and I. Ingrand, Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study, Pharmacoepidemiology and Drug Safety, vol.57, issue.8463, pp.952-60, 2013.
DOI : 10.1002/pds.3471

M. Guenette, A. Chintoh, R. G. Hahn, and M. , Atypical Antipsychotic-Induced Metabolic Disturbances in the Elderly, Drugs & Aging, vol.35, issue.12, pp.159-84, 2014.
DOI : 10.1007/s40266-014-0152-x

R. Aparasu, S. Chatterjee, and H. Chen, Risk of Pneumonia in Elderly Nursing Home Residents Using Typical Versus Atypical Antipsychotics, Annals of Pharmacotherapy, vol.60, issue.2, pp.464-74, 2013.
DOI : 10.1093/aje/kwj149

V. Bali, S. Chatterjee, and M. Johnson, Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors, Journal of Comparative Effectiveness Research, vol.5, issue.5
DOI : 10.2217/cer-2016-0009

S. Chatterjee, R. Carnahan, and H. Chen, Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study, Journal of the American Geriatrics Society, vol.60, issue.Suppl 3, pp.394-400, 2016.
DOI : 10.1111/jgs.13932

A. Gallini, J. Donohue, and H. Huskamp, Diffusion of Antipsychotics in the U.S. and French Markets, 1998???2008, Psychiatric Services, vol.64, issue.7, pp.680-687, 1998.
DOI : 10.1176/appi.ps.004662012

J. Schulze, H. Van-den-bussche, and G. Glaeske, Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances, European Neuropsychopharmacology, vol.23, issue.9, pp.1034-1076, 2013.
DOI : 10.1016/j.euroneuro.2013.02.001

A. Gallini, S. Andrieu, and J. Donohue, Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings, European Neuropsychopharmacology, vol.24, issue.1
DOI : 10.1016/j.euroneuro.2013.09.003

A. Palmaro, J. Dupouy, and M. Lapeyre-mestre, Benzodiazepines and risk of death: Results from two large cohort studies in France and UK, European Neuropsychopharmacology, vol.25, issue.10, pp.1566-77, 2015.
DOI : 10.1016/j.euroneuro.2015.07.006

A. Nørgaard, C. Jensen-dahm, and C. Gasse, Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study, Journal of Alzheimer's Disease, vol.49, issue.1, pp.211-231, 2015.
DOI : 10.3233/JAD-150481

J. Sultana, A. Fontana, and F. Giorgianni, The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study, CNS Drugs, vol.19, issue.4, pp.10-1007, 2016.
DOI : 10.1007/s40263-016-0366-z